Barbara Savoldo Archives - UNC Lineberger

November 25, 2025

OncLive: Intraventricular B7-H3–Targeted CAR T-Cell Therapy Displays Safety in Recurrent Glioblastoma

A person wearing head-to-toe medical protective garments at a hooded work station in the Advanced Cellular Therapeutics Facility. They are pipetting into a container.

The Foundation for the Accreditation of Cellular Therapy awarded accreditation without any deficiency citations to UNC Lineberger’s Advanced Cellular Therapeutics Facility.

Barbara Savoldo, MD, PhD, and Stephanie Wheeler, PhD, MPH, were recently approved as named distinguished professors, one of the highest honors a university bestows to a faculty member.

AACR: American Association for Cancer Research.

Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.

A person wearing PPE looking into a microscope.

UNC Lineberger researchers are using CAR-T to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.

Headshots of the 12 UNC Lineberger members who are listed on Clarivate’s 2023 Highly Cited Researchers list.

Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.

Exteriors of the UNC Lineberger and Marsico Hall buildings.

Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.

Fifteen UNC Lineberger Comprehensive Cancer Center members were named as 2021 Highly Cited Researchers by Clarivate for publishing some of the most influential scientific papers during the past decade.

Researchers from UNC Lineberger and colleagues report pairing a newly developed gel with immunotherapy that was delivered to post-surgical lab models with glioblastoma improved the immunotherapy’s effectiveness.

Headshots of Hongwei Du and Gianpietro Dotti

Hongwei Du, PhD, Gianpietro Dotti, MD, and colleagues developed a new therapeutic approach that has shown successful results in lab models.

Tag: Barbara Savoldo

OncLive: Intraventricular B7-H3–Targeted CAR T-Cell Therapy Displays Safety in Recurrent Glioblastoma

UNC Lineberger’s Advanced Cellular Therapeutics Facility earns accreditation

Investing in named professorships to attract and retain world-class faculty

UNC researchers present at American Association for Cancer Research’s 115th Annual Meeting

Curated cancer care

UNC Lineberger faculty named world’s most highly cited researchers

UNC Lineberger faculty recognized as world’s most highly cited researchers

UNC Lineberger faculty recognized as being among the world’s most influential researchers

Gel enhances CAR-T immunotherapy benefits in brains surgically treated for glioblastoma

Therapy using dual immune system cells effectively controls neuroblastoma